Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vitamin D and multiple sclerosis.
Inflammatory demyelinating diseases in children: an update.
Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.
Fingolimod after natalizumab and the risk of short-term relapse.
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
An introduction with medical applications to functional data analysis.
A validated regulatory network for Th17 cell specification.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Incorporating real-world clinical practice in multiple sclerosis economic evaluations.
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis.
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease.
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Pages
« first
‹ previous
…
341
342
343
344
345
346
347
348
349
…
next ›
last »